“…A postchemoradiation extrafascial hysterectomy was part of the treatment in GOG123 [46], the work by Keys et al [24], and in single-institution studies [1,5,22,25,32,44]. The concern that this leads to an excess in toxicity was not confirmed in recent series [5,25] while a significant benefit toward local control [24,25,32], progression-free survival [25] and a favorable trend toward overall survival were suggested [5,25].…”